# Open-label Evaluation of Polymyxin B Hemoperfusion for Septic Shock

> **NCT02825329** · — · TEMPORARILY_NOT_AVAILABLE · sponsor: **Spectral Diagnostics (US) Inc.**

## Conditions studied

- Septic Shock
- Endotoxemia

## Interventions

- **DEVICE:** TORAYMYXIN PMX-20R

## Key facts

- **NCT ID:** NCT02825329
- **Lead sponsor:** Spectral Diagnostics (US) Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** TEMPORARILY_NOT_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02825329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02825329, "Open-label Evaluation of Polymyxin B Hemoperfusion for Septic Shock". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02825329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*